✦ LIBER ✦

Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study

✍ Scribed by Michael BOYER; Keith HORWOOD; Nick PAVLAKIS; Paul DE SOUZA; Michael MILLWARD; Brian STEIN; Michael JOHNSTON; Fiona ABELL; Danny RISCHIN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6510 ORAL Erlotinib in patients with adv

✍ Smit, E.; Reck, M.; Krzakowski, M.; Gridelli, C.; Curescu, S.; Berzinec, P.; Bar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Second-line erlotinib in patients with a

✍ Heigener, David F.; Wu, Yi-Long; van Zandwijk, Nico; Mali, Pekka; Horwood, Keith 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Erlotinib treatment results in patients

✍ Salajka, F.; Pešek, M.; Skřičková, J.; Zatloukal, P.; Koubková, L.; Grygárková, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical efficacy of erlotinib in patien

✍ Songwen ZHOU; Shengxiang REN; Lianghua YAN; Ling ZHANG; Liang TANG; Jie ZHANG; C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

9174 Phase II study of everolimus plus e

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB